Impact of natalizumab treatment on fatigue, mood and aspects of cognition in relapsing-remitting multiple sclerosis

Impact of natalizumab treatment on fatigue, mood and aspects of cognition in relapsing-remitting multiple sclerosis

Background/ObjectiveFatigue, cognitive and affective disorders are relevant symptoms in Multiple Sclerosis (MS). The treatment with Natalizumab has a positive effect on physical disabilities in patients with RRMS. Some studies describe improvements in cognition and fatigue over one year of treatment...

Full description

Bibliographic Details
Main Authors: Annett eKunkel, Martin eFischer, Judith eFaiss, Doreen eDaehne, Wolfgang eKöhler, Jürgen H. eFaiss
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-05-01
Series:Frontiers in Neurology
Subjects:
Cognition
Depression
Fatigue
Multiple Sclerosis
natalizumab
Online Access:http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00097/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00097/full

Similar Items